Evidence map›Paper›PMID 29740399›Full record

ReviewFrontiers in endocrinology2018

The Emerging Role(s) for Kisspeptin in Metabolism in Mammals.

Andrew Wolfe, Mehboob A Hussain

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 77 citations in OpenAlex.

  1. Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.The Journal of clinical endocrinology and metabolism · 2022
    Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Adipose Kiss1 controls aerobic exercise-related adaptive responses in adipose tissue energy homeostasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Endocrinopathies and Male Infertility.Life (Basel, Switzerland) · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Andrew WolfeDepartment of Pediatrics, Johns Hopkins University, Baltimore, MD, United States.
Mehboob A HussainDepartment of Internal Medicine Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, United States.
Johns Hopkins University · USUniversity of Michigan–Ann Arbor · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI AHIMA, REXFORD S. · 2013 to 2017
$9.7M
Sex Steroids, Kisspeptin and Regulation of GnRHR01HD068777 · NICHD · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI HOFFMAN, GLORIA E, LEVINE, JON E · 2012 to 2016
$2.4M
Hepatic endocrine suppression of the pancreatic beta-cellR01DK101591 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HUSSAIN, MEHBOOB A, WOLFE, ANDREW M · 2014 to 2017
$2.0M
NICHD NIH HHS R01 HD068777NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK079637NIDDK NIH HHS R01 DK101591
6 · The paper itself

Abstract

Kisspeptin was initially identified as a metastasis suppressor. Shortly after the initial discovery, a key physiologic role for kisspeptin emerged in the regulation of fertility, with kisspeptin acting as a neurotransmitter

Indexed as

adipocyteskisspeptinlivermouse modelsobesitypancreas

Identifiers

PMID29740399
PMCPMC5928256
OpenAlexW2800185702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.